LUP Statistics
Record
- Title
- Läkemedelsindustrin och marknadsuppdelning inom EU - Immaterialrättsliga hinder, konkurrensrättsliga möjligheter? The pharmaceutical industry and market partitioning within the EU - A study of IP- and competition law related aspects.
- Type
- Student Paper
- Publ. year
- 2006
- Author/s
- Fagerström, Charlotta
- Department/s
- Department of Law
- In LUP since
- 2010-03-08
Downloads
| Total | This Year | This Month |
| 732 | 22 | 1 |
Sweden  |
399 (55%) |
China  |
133 (18%) |
Germany  |
64 (9%) |
United States of America  |
40 (5%) |
Denmark  |
9 (1%) |
Finland  |
8 (1%) |
Hong Kong (China)  |
6 (1%) |
Norway  |
6 (1%) |
Belgium  |
5 (1%) |
United Kingdom of Great Britain and Northern Ireland  |
5 (1%) |
Italy  |
5 (1%) |
France  |
5 (1%) |
Russian Federation  |
4 (1%) |
Taiwan (China)  |
4 (1%) |
Nigeria  |
3 (0%) |
Austria  |
3 (0%) |
Thailand  |
2 (0%) |
Unknown  |
2 (0%) |
South Korea  |
2 (0%) |
Canada  |
2 (0%) |
Ireland  |
2 (0%) |
Netherlands (Kingdom of the)  |
2 (0%) |
Australia  |
2 (0%) |
European Union location  |
2 (0%) |
Bulgaria  |
1 (0%) |
Bangladesh  |
1 (0%) |
Afghanistan  |
1 (0%) |
Greece  |
1 (0%) |
Ghana  |
1 (0%) |
Indonesia  |
1 (0%) |
India  |
1 (0%) |
Brazil  |
1 (0%) |
Iraq  |
1 (0%) |
Mexico  |
1 (0%) |
Switzerland  |
1 (0%) |
Tajikistan  |
1 (0%) |
Spain  |
1 (0%) |
Croatia  |
1 (0%) |
Sri Lanka  |
1 (0%) |